Evidence map›Paper›PMID 31537900›Full record

ArticleBone marrow transplantation2020

Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.

Takayoshi Tachibana, Takuma Ishizaki, Satoshi Takahashi, Yuho Najima, Shun-Ichi Kimura, Emiko Sakaida, Makoto Onizuka, Takehiko Mori, Shin Fujisawa, Shin-Ichiro Fujiwara and 11 more

Abstract readLetterMulticenter Study
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 1 country.

Takayoshi TachibanaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan. tcbn@kcch.jp.ORCID http://orcid.org/0000-0002-7780-4459
Takuma IshizakiDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
Satoshi TakahashiDivision of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Yuho NajimaHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Shun-Ichi KimuraDivision of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Emiko SakaidaDepartment of Hematology, Chiba University Hospital, Chiba, Japan.ORCID http://orcid.org/0000-0002-7254-1928
Makoto OnizukaDepartment of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Takehiko MoriDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8176-4760
Shin FujisawaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
Shin-Ichiro FujiwaraDivision of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
Takeshi SaitoDivision of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Maki HagiharaDepartment of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan.
Nobuyuki AotsukaDivision of Hematology-Oncology, Japanese Red Cross Society Narita Hospital, Narita, Japan.
Moritaka GotohFirst Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan.
Kensuke UsukiDepartment of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
Nobuhiro TsukadaDepartment of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Junya KandaDivision of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.ORCID http://orcid.org/0000-0002-6704-3633
Heiwa KanamoriDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Yoshinobu KandaDivision of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Kanto Study Group for Cell Therapy (KSGCT)
Jichi Medical University · JPGunma University · JPJikei University School of Medicine · JPKeio University · JPTokai University · JPTokyo Medical University · JPJapanese Red Cross Narita Hospital · JPKanagawa Prefectural Hospital Organization · JPKyoto University · JPNTT Medical Center · JPTokyo Metropolitan Komagome Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteHumansRetrospective StudiesTransplantation Conditioning

Identifiers

PMID31537900
OpenAlexW2973786351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.